Found 11 matching trials
Pharmacokinetic of Intravenous Iron Sucrose in Adolescents on Hemodialysis or Peritoneal Dialysis Receiving Epoetin PHASE2 This is an open-label, multicenter pharmacokinetic study of Hemodialysis (H...
Show More Location
Multiple Locations
Learn More & Join Trial
Anemia Studies in CKD: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat- Iron (ASCEND: Fe) PHASE2 Daprodustat administration has the potential, by virtue of increasing hypox...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Traumatic Optic Neuropathy Treatment Trial 2 PHASE3 After introducing intravenous erythropoietin (EPO) as an option for treatme...
Show More Location
Iran University of Medical Sciences
Learn More & Join Trial
Comparison Study of Standard Care Against Combination of Growth Factors Agents for Low-risk Myelodysplastic Syndromes PHASE3 REGIME is comparing two treatments, with Darbepoetin Alpha (DA) and Filgras...
Show More Location
Birmingham Cancer Research UK Clinical Trial Unit
Learn More & Join Trial
A Study Comparing The Effects Of Epoetin Hospira Single-Dose Vial (SDV) And Multi-Dose Vial (MDV) When Administered Subcutaneously To Normal Healthy Subjects PHASE1 This study will assess the PK similarity of epoetin administered as Hospira...
Show More Location
Pfizer New Haven Clinical Research Unit
Learn More & Join Trial
High-dose Erythropoietin for Asphyxia and Encephalopathy PHASE3 Hypoxic-ischemic encephalopathy (HIE) occurs when a baby gets reduced blood...
Show More Location
Children's Hospital Los Angeles
Learn More & Join Trial
Erythropoietin (Epo) and Venofer Trial After Autologous Hematopoietic Stem Cell Transplantation (HSCT) PHASE2 Darbepoetin-alpha and i.v. iron administration after autologous hematopoiet...
Show More Location
Vrije Universiteit Brussel
Learn More & Join Trial
Erythropoietin Therapy for Subarachnoid Hemorrhage PHASE2 ABSTRACT:
Delayed ischemic deficits (DID) and strokes caused by low cerebr...
Show More Location
Department of Neurosurgery, Addenbrooke's Hospital
Learn More & Join Trial
A Study of Intravenous or Subcutaneous Methoxy Polyethylene Glycol-Epoetin Beta (RO0503821, Mircera) in Chronic Kidney Disease Patients With Renal Anemia PHASE3 This study assessed the long-term efficacy, safety, and tolerability of int...
Show More Location
Multiple Locations
Learn More & Join Trial
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Three-times Weekly Dosing in Dialysis (ASCEND-TD) PHASE3 This Phase 3 study in hemodialysis-dependent subjects with anemia will eval...
Show More Location
GSK Investigational Site
Learn More & Join Trial